Advanced Research Projects Agency for Health (ARPA-H) BREATHE Program

The Advanced Research Projects Agency for Health (ARPA-H) BREATHE program has awarded a contract of up to $40 million to a multi-institutional research team led by Virginia Tech. Washington University in St. Louis, in collaboration with Agilus Detection, will receive $15 million to develop commercial-ready devices that disrupt the transmission of infectious diseases in indoor environments. The research project, called Bioaerosol Risk Assessment interVention Engineering (BRAVE), aims to reduce respiratory illnesses such as cold, flu, and asthma by 25% with an innovative clean-air version of a fire suppression system.

Agilus Detection's Deliverables Roadmap

Phase I: Prototype & Sensor Engineering 

(September 2025 – August 2027)

• February 2026 (Month 6): Design and prototype of BioAeroPlex1 (single target airborne pathogen detection)

• November 2026 (Month 15): 10-Plex Biosensor Module

• February 2027 (Month 18): 15-Plex Biosensor Module

• August 2027 (Month 24): Alpha Prototype (BioAeroPlex25) of Fully-Integrated Wet-cyclone + 25-Plex Biosensor Module

Phase II: Validation & Refinement 

(September 2027 – August 2028)

• November 2027 (Month 27): Chamber-Deployable Alpha Unit (BioAeroPlex25)

• August 2028 (Month 36): Manufacturing-Ready Beta Prototypes (BioAeroPlex25)

Phase III: Scale & High-Throughput 

(September 2028 – August 2030)

• February 2029 (Month 42): Proof of Concept for 50-Plex Biosensor Module

• August 2029 (Month 48): Proof of Concept for 100-Plex "Century" Module

• May 2030 (Month 57): Final Commercial Beta Prototype Design